STAHL NEIL bought REGN
February 2, 2024 · Form 4 insider transaction
STAHL NEIL bought 30,750 shares of Regeneron Pharmaceuticals, Inc. at $399.66 per share, a transaction worth $12.29M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,750
Price
$399.66
Total value
$12.29M
InsiderSTAHL NEIL
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 2, 2024
Filing dateFebruary 6, 2024
Shares owned after82,769
OwnershipDirect
10b5-1 planNo
AmendedNo